Osage University Partners has promoted four across its finance and investment teams, including that of healthcare-focused senior associate Stephanie Stehman to the position of principal.
US-based spinout-focused investment firm Osage University Partners (OUP) promoted four members across its finance and investment teams yesterday.
Claudia Dunnous, previously vice-president of finance, will now act as chief financial officer for both OUP and its sister fund, Osage Venture Partners.
Dunnous has more than 25 years of experience working in the private equity and manufacturing sectors. She joined OUP in 2006 after serving as vice-president of finance and operations at colour pigment producer Hamburger Color.
Beth Grafstrom, former fund controller at OUP, has been promoted to vice-president of finance. Grafstrom began working at OUP in 2015 after having been a business development company controller at investment group New Mountain Capital.
Two members of the firm’s investment team have also been promoted. Stephanie Stehman, formerly a senior associate, has been promoted to the position of principal.
Stehman brings investment expertise in the therapeutics, diagnostics and medical devices sectors. Since joining Osage from VC firm HIG Bioventures in 2015, Stehman has been involved with seven portfolio businesses, including Fortis Therapeutics, a US-based immuno-oncology spinout from University of California, San Francisco.
Finally, associate David Dorsey has been promoted to senior associate. Dorsey, who started with Osage University Partners in 2016 after seven years as lead engineer with aerospace firm Lockheed Martin, primarily covers investments in networks, wireless technology, signal processing and machine learning.
Both Stehman and Dorsey previously published guest comments in the Global University Venturing magazine.
